PCSK9 inhibitors reduces arterial stiffness in patients with acute coronary syndrome

Background: This study focuses on uncovering the effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in attenuating arterial stiffness in patients with acute coronary syndrome (ACS) and atherosclerosis. Methods: A total of 71 ACS patients were enrolled in this study from Apri...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Liang, Wang Ruijie, Jiao Tiantian, Xu Linghao, Ji Endong, Jiang Yuanzhen, Wang Yuanqi, Liu Yehong, Li Jiming
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2025-01-01
Series:Journal of Medical Biochemistry
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582503412W.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!